SecBot SecBot
8-K ·Filed Oct 27, 2026

IMNN

Imunon, Inc.
NEUTRAL
Impact 2/10
Processed8h 59m ago SEC0001493152-26-048625
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-048625
Document: 0001493152-26-048625-index-headers.html0001493152-26-048625
Document: 0001493152-26-048625-index.html0001493152-26-048625
Document: 0001493152-26-048625.txt0001493152-26-048625
13 reports for IMNN
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +23.81%Jun 4, 2026
Filters
Rows
Reports for IMNN — sortable, filterable
TypeNow
Oct 27, 2026
today
S-1
BEARISH ★ 6/10
$1.22awaiting T+5—$0.9100 (+25.41%)
Oct 27, 2026
today
8-K
NEUTRAL ★ 2/10
$1.25awaiting T+5—$0.9100 (−27.20%)
Oct 21, 2026
6d ago
8-K
NEUTRAL ★ 4/10
$1.19awaiting T+5—$0.9100 (−23.53%)
Sep 29, 2026
28d ago
8-K
BEARISH ★ 5/10
$1.34 $1.12▲ +16.10%▲ +18.05%$0.9100 (+31.84%)
Aug 11, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$1.61 $1.58▼ −1.86%▼ −1.42%$0.9100 (−43.48%)
Aug 11, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$1.61 $1.58▼ −1.86%▼ −1.46%$0.9100 (−43.48%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$1.88 $1.95▲ +3.72%▲ +3.46%$0.9100 (−51.60%)
Jun 16, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$1.86 $1.73▼ −6.99%▼ −5.95%$0.9100 (−51.08%)
Jun 4, 2026
20w ago
8-K
BEARISH ★ 6/10
$2.10 $2.03▲ +3.33%▲ +0.78%$0.9100 (+56.67%)
May 12, 2026
24w ago
8-K
BULLISH ★ 6/10
$2.70 $2.26▼ −16.30%▼ −16.37%$0.9100 (−66.30%)
Showing 10 of 13

US Market Status

Market Open — Closes in 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 27, 2026

Fresh IMNN Intelligence

Analysis is for subscribers only.

Subscribe for Full Access